Literature DB >> 8224642

Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy.

N J Talley1, A L Weaver, D L Tesmer, A R Zinsmeister.   

Abstract

BACKGROUND: The subdivision of undiagnosed patients with dyspepsia into symptomatic subgroups (ulcerlike, dysmotilitylike, refluxlike, and nonspecific) may give a clue to the underlying cause; however, the value of this approach in practice is unclear. This study aimed to determine the discriminant value of dyspeptic symptoms and combinations of these symptoms.
METHODS: A consecutive sample of 820 outpatients (median age, 62 years; 47% male) completed, before endoscopy, a validated questionnaire that measured 46 gastrointestinal symptoms.
RESULTS: Of patients with functional dyspepsia (n = 162), 17% had ulcerlike, 9% dysmotilitylike, and 16% refluxlike dyspepsia alone; 31% fell into two or more symptom subgroups; and 27% had nonspecific symptoms. A similar distribution of the dyspepsia subgroups was observed in patients without functional dyspepsia. Younger age, female gender, frequent upper abdominal pain, no (or sometimes) pain relief with antacid use, and infrequent vomiting were predictive of functional dyspepsia vs. all other diagnoses (at a specificity of 80%, the sensitivity was 60%). The dyspepsia subgroups were poor discriminators in a separate model for functional dyspepsia vs. all other diagnoses (at a specificity of 80%, the sensitivity was only 43%).
CONCLUSIONS: The dyspepsia subgroups, as currently defined, appear to have little clinical utility and may be an inappropriate way of classifying dyspepsia.

Entities:  

Mesh:

Year:  1993        PMID: 8224642     DOI: 10.1016/0016-5085(93)90142-y

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  42 in total

Review 1.  ACP. Best practice no 154. February 1999. Helicobacter pylori.

Authors:  C A McNulty; J I Wyatt
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

2.  Design of treatment trials for functional gastrointestinal disorders.

Authors:  S J Veldhuyzen van Zanten; N J Talley; P Bytzer; K B Klein; P J Whorwell; A R Zinsmeister
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

3.  Significance of autonomic nervous system activity in functional dyspepsia.

Authors:  E R Muth; K L Koch; R M Stern
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

4.  Lump or split dyspepsia? A continuing controversy.

Authors:  N J Talley; S Thitiphuree
Journal:  Curr Gastroenterol Rep       Date:  2001-06

5.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  W H Allum; S M Griffin; A Watson; D Colin-Jones
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

Review 6.  Helicobacter pylori eradication in patients with non-ulcer dyspepsia.

Authors:  H H Xia; N J Talley
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

7.  Evaluation and management of dyspepsia.

Authors:  R Christopher Harmon; David A Peura
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

Review 8.  How should Helicobacter pylori negative patients be managed?

Authors:  V Stanghellini; C Tosetti; R De Giorgio; G Barbara; B Salvioli; R Corinaldesi
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

9.  Predictive value of alarm features in a rapid access upper gastrointestinal cancer service.

Authors:  N Kapoor; A Bassi; R Sturgess; K Bodger
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

10.  Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population.

Authors:  T M Kennedy; R H Jones; A P Hungin; H O'flanagan; P Kelly
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.